The specialty of colon and rectal surgery, a specialty of general surgery, has evolvedfrom the field of proctology. Clinical care has demonstrated decreased number of patients requiring intestinal stomas, improved quality of life in patients with benign anorectal disorders, and more favorable results in patients afflicted with primary and recurrent colorectal cancer. Basic science investigations have spawned from clinical questions such as the molecular biology of colorectal cancer, use of cyclooxygenase inhibitors and polyp regression, and novel cytokine antagonists in inflammatory bowel disease. Medical students are exposed to surgeons with expertise in anorectal anatomy and physiology, mechanisms ofcarcinogenesis and the importance ofscreening for detection ofcolorectal cancer, and novel therapies for inflammatory bowel disease. Surgical residents benefit by having a colorectal surgeon on the faculty by repetitive exposure to anorectal surgery, low pelvic anastomoses, stoma creation and closure, and surgery involving the small intestine. Senior colorectal surgeons will develop critical pathways for the healthcare delivery ofpatients afflicted with colorectal disease. The specialty ofcolorectal surgery will continue to translate into improved patient care and positively impact in academic medicine by providing expertise into student and resident training and generate highly sophisticated clinical and basic science investigations.
INTRODUCTION
The controversy over specialization in medicine has existed for almost 100 years. Specialization has evolved to provide care for specific populations, for explicit services and as a result of new technology. Clearly, the healthcare market demands driven by the consumer have championed demands to no end. Specialization provides state-ofthe-art knowledge and care of complex areas, high volumes of routine procedures, educational benefits to students and those in postgraduate training and intangibly provides the answers to questions that continue to appear in the clinical arena that need to be translated from bench research to evidenced based medicine. This is all so true for the specialty of colon and rectal surgery. The surgical anatomy is challenging; physiology is better understood but unknown to those outside the specialty; pharmacology is playing a crucial role as in the mediators of the anal sphincters; and pathology is neverending. Clinically, the issues are challenging: fears of stomas in cancer surgery, young adults undergoing major intestinal resections for inflammatory bowel disease, lifealtering bowel dysfunction in patients with fecal incontinence and constipation, and anal disease that if mismanaged can be quite costly to the patient and surgeon. The opportunities for investigation are numerous and include colorectal cancer genetics, biological therapies for colorectal cancer, mediators of inflammation, implantable devices, tissue engineered intestine and robotics. This review will discuss the specialty of colon and rectal surgery as it relates to its evolution, training and board certification, spectrum of clinical activity, educational initiatives, and frontiers of research. [5] . Therapy can be broadly categorized into oral therapy such as fiber, topical treatments, nonsurgical destructive techniques, and surgical intervention. The decision to treat is based on the nature, frequency, and severity of symptoms. It is also based upon patient preference and operator experience. The overwhelming majority of patients who seek treatment will receive conservative therapy where the goal is to relieve symptoms and maintain remission. Fiber supplements and increased water intake are often first-line therapy, however the results remain inconsistent. Regardless, fiber supplements given over six weeks are superior versus placebo for reduction of bleeding symptoms [6] . It will remain first-line therapy because it is safe and inexpensive. Topical therapies reduce symptoms by exerting a local anesthestic effect eliminating the symptoms of burning and itching. A number of topical therapies are available. Only one randomized trial utilizing 5-ASA suppositories demonstrated significant reduction in hemorrhoidal symptoms when compared to placebo [7] . Bleeding or other symptoms that persist despite conservative management require more aggressive therapy. This entails either non-surgical options or surgical hemorrhoidectomy. The goal of non-surgical therapy is tissue fixation of the hemorrhoid pedicle. These methods include rubber band ligation, injection sclerotherapy, and infrared coagulation. None of these techniques have been investigated individually against placebo-controlled trials [8] . However, randomized trials comparing these modalities with each other have been performed. These results failed to demonstrate a clear advantage and appear to be equally effective. Two metaanalyses [9, 10] [18] . In patients with high trans-sphincteric fistulas and suprasphincteric fistulas, consideration to a anorectal advancement flap should be given [19] . Extrasphincteric fistulas, which are exceedingly rare, depend on the etiology (abscess, Crohn's disease, or foreign body) and often require fecal diversion along with eliminating the fistula. Impaired [24] . In properly selected patients, the ileoanal pouch anastomosis provides patient satisfaction at over 90 percent [25] . [27, 28] . Similarly, conservative resectional treatment involving the colon also continues to evolve [29] .
EVOLUTION OF THE SPECIALTY
Two areas deserve special interest, they being acute surgical emergencies and perianal Crohn's disease. The HNPCC is an autosomal dominant inherited disorder that accounts for 3 to 5 percent of all colorectal cases. It is caused by a mutation in any one of the five mismatch repair genes. Colorectal cancer arises from a single flat polypoid lesion in the absence of polyposis. It is characterized by a young age for developing colorectal cancer, multiple tumors, proximal lesions, and metachronous tumors within 10 years of resection. Similar to FAP, other cancers can occur in HNPCC especially gynecological. The phenomenon on microsatellite instability is found in 90 percent of HNPCC tumors and is the first step in genetic testing followed by MMR gene testing to confirm the diagnosis. In a patient with HNPCC who develops colorectal cancer, subtotal colectomy with ileorectal anastomosis is recommended. Postoperative endoscopic surveillance should be performed every six months [34] . It is uncertain whether prophylactic hysterectomy and oophorectomy is indicated.
Rectal and anal cancer
The management of rectal cancer has progressed tremendously over the past 100 years, in part because of an increased understanding of the pathology and natural history of the disease [35] . Currently, surgery remains the mainstay of therapy and includes a spectrum of operative procedures both radical and local with a trend towards increased number of sphincter sparing procedures. Preoperative diagnostic imaging has provided preoperative assessment of locoregional and distant disease and aids in decisions of whether to employ preoperative neoadjuvant therapy involving radiation and chemotherapy [35] . Regardless, outcome appears to be related to tumor biology, stage of the lesion at presentation, and type of operation performed. Recently, the impact of the surgeon performing the operation may also influence outcome [36] . Preoperative imaging remains an essential part of the assessment of the patient with rectal cancer. CT is useful in assessing patients thought to harbor extensive local or metastatic disease. Endorectal ultrasound is the best method for evaluating loco-regional disease. It is highly accurate for detecting depth of invasion and less so for perirectal lymph nodes. Magnetic resonance imaging (MRI) can also detect local tumor extension. Nuclear medicine techniques utilizing either flurodeoxyglucose positron emission tomography (FDG-PET) and immunoscintigraphy are utilized to detect occult or recurrent cancer [35] [40] .
Many patients can be managed by means of pharmaceutical products such as antidiarrheals or behavioral modification such as biofeedback. Daily colonic irrigation remains another alternative but has potential adverse sequelae. A number of surgical procedures are available for the treatment of anal incontinence. Most operations attempt to restore the sphincter mechanism and anorectal angle. These include either anorectal muscle repairs such as direct apposition and overlapping sphincteroplasty or total pelvic floor repair [41] . Severe multifocal damage to the sphincter complex may not be suitable for direct sphincter repair and require either a static or dynamic neosphincter repair [42] . These include gluteus and gracilis muscle transpositions or free muscle transpositions involving sartorius muscle. Implantation of an artificial sphincter was initially popularized in 1992 and remains under investigation [43] . Finally, the creation of an intestinal stoma remains the last option for treatment of incontinence. This can be performed laparoscopically. Neurogenic incontinence remains a difficult condition and may benefit by biofeedback and other conservative measures [44] .
Functional and pelvic floor disorders
The majority of functional pelvic floor disorders are the result of or result in abnormal defecatory habits. Often these disorders have constipation as the predominant symptom [45] . Sophisticated physiological testing and diagnostic imaging techniques have identified the etiology of many of these defecatory disorders and resulted in therapies to patients who would have previously been ignored. Paradoxical or non-relaxing puborectalis syndrome (anismus) occurs when the puborectalis inappropriately contracts or fails to relax during defecation resulting in pelvic outlet obstruction. The diagnosis is confirmed with a combination of anorectal manometry, electromyography and cinedefecography. Biofeedback therapy is the initial treatment of choice [46] . Treatment failures may respond to Botox injections. Surgery has no role. The Descending Perineum Syndrome has a similar presentation as anismus with obstructed defecation as the predominant symptom. It is felt to be secondary to many years of straining to defecate. It is diagnosed by perineometric measurements and cinedefecography. Treatment is limited to nonoperative methods including biofeedback. A rectocele may also produce obstructed defecation. The diagnosis is made by a history of straining and the need for digital rectal or vaginal evacuation. Physical examination provides the diagnosis in about two-thirds of cases where the rectum is seen bulging into the vagina. Defecography will reveal the rectocele and provide useful information about the anorectal angle. Treatment is initially conservative. Surgery is recommended for patients rectocele's greater than 4 cm partial emptying during defecography and the need to digitally evacuate. A wide range of transvaginal, transrectal, and transperineal procedures have been advocated with variable success. Rectal prolapse is full thickness protrusion of the rectum through the anal sphincters. Internal or "hidden" prolapse occurs when the rectum intusscepts, but does not pass beyond the anal canal. Symptoms include protrusion, bleeding, fecal incontinence, and a sense of incomplete rectal emptying. Full thickness rectal prolapse must be differentiated from rectal mucosal prolapse seen in association with advanced hemorrhoidal disease. Management of rectal prolapse is surgical [47] . Over 100 procedures have been described. They may either be abdominal or perineal. Normal anatomy is restored. A widely variable effect of prolapse surgery on disturbed evacuation occurs. Continence is often restored.
Intestinal stomas and alternatives to conventional ileostomy
During the first half of the twentieth century, an ileostomy was associated with significant morbidity secondary to serositis of the exposed bowel wall. This was rectified by the development of the technique of an everting ileostomy in 1952 by Brooke [48] . This dramatically changed surgical treatment and life with an ileostomy. Nevertheless, patient dissatisfaction of a constantly draining stoma and the requirement of a full-time pouch caused physicians to develop alternatives. In 1969, Nils Kock [49] described the creation of an ileal reservoir drained by an access segment through the rectus muscle. He modified this with a nipple valve of intusscepted ileum creating complete continence. A further modification was proposed by William Barnett who developed the Barnett reservoir utilizing a living collar of ileum wrapped around the neck of the pouch to improve continence [50] . The utility of these procedures has diminished as a direct consequence of the creation of the ileoanal pouch for the treatment of ulcerative colitis and familial adenomatous polyposis. Although pouch salvage following anal and perineal complications of restorative proctocolectomy continue to improve, there is a role for a continent ileal stoma in the even the pouch can not be salvaged [51, 52] .
Anorectal physiological testing
Manometric, electrophysiologic and radiologic techniques used in combination provide important basic information necessary to understand anorectal and pelvic floor disorders. Anorectal physiological testing evaluates the function of the anorectum, pelvic floor, and anal sphincters [53] . Its utility centers mostly on the evaluation of fecal incontinence [54] . The [64] . Angiogenesis appears to have come to the forefront of colorectal cancer investigation with the realization that the growth of tumors is dependent on angiogenic factors [65] . Chemoprevention involving dietary supplements such as calcium and folic acid or the daily administration of compounds that block critical enzyme pathways implicated in carcinogenesis such as cyclooxygenase continue to receive attention [66] . Continued emerging surgical technology will involve reducing surgical stress and its potential immunologic consequences by utilizing surgical trauma.
Understanding the mechanisms of the inflammatory cascade and use of novel cytokine antagonists, growth hormone and colon stimulating factors have and will continue to impact favorably in intestinal inflammatory states. Inflixamib (Remicaid) is a anti-tumor necrosis factor compound which has had a major impact in refractory fistulizing Crohn's disease involving the intestine and the anorectum. From this landmark study, it is reasonable to assume that other compounds will be developed to regulate the inflammatory cascade. This will clearly be aided by the further understanding of the molecular events that occur during inflammation.
Surgeons with expertise in colon and rectal surgery are often called upon by their medical counterparts to evaluate patients with a variety of functional bowel disorders often manifested by abdominal or pelvic pain, cramping, constipation, diarrhea and incontinence. The benefits of colectomy for chronic constipation in highly selected patents and a combination of bowel retraining, biofeedback, and, where applicable, anal sphincter repair for fecal incontinence have been well established. However, a tremendous amount of time and healthcare resources have been utilized in patients with other functional disorders often with variable or unfavorable results. Recent advances in the understanding of neurotransmitters and gut hormones that regulate intestinal physiology have come to the forefront. After many years of failure of compounds such as cholinergic agonists and dopamine antagonists, highly focused research has directed physicians to learn how to manipulate the serotoninergic (5-hydroxytryptamine-5HT) mechanisms within the gut. A number of significant advances including 5-HT3 antagonists for diarrhea predominant irritable bowel and 5-HT4 agonists for constipation irritable bowel have been met with favorable results [67] .
CONCLUDING REMARKS
Colon and rectal surgery is a true specialty. Expertise can have a favorable impact on patients afflicted with afflictions of the colon, rectum, and anus. It will impact favorably on patients who develop rectal cancer by both increased number of sphincter preserving procedures and decreased local recurrence, increased the number and quality of restorative procedures for ulcerative colitis, offer alternatives for patients with disabling fecal incontinence, result in diminished complications following surgery for benign anorectal disease and overall diminish the number of patients who require an intestinal stoma. Within the academic setting, the path is clearly paved for novel and influential research initiatives in both the basic sciences and translational research. Its multifactorial role in education, character building and as a role model has yet to be fully realized but will continue to come of age.
